Literature DB >> 8383004

Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms.

J F Muindi1, C W Young.   

Abstract

Cytochrome P-450 enzymes have been implicated in the oxidative catabolism of all-trans-retinoic acid (RA), a process that is accelerated by exposure to RA in cultured cells and rodents, and also in patients receiving RA as treatment for cancer (J.F.R. Muindi et al., Cancer Res., 52: 2138, 1992; Blood, 79: 299, 1992). Accelerated oxidation of RA could arise from an induction of RA-catabolizing P-450 isoforms or from an increase in oxidative cofactors. We have examined the efficiency of NADPH/O2 and lipid hydroperoxides (LOOH) to support oxidation of RA using human cell microsomes genetically enriched in different P-450 isoforms. The observed rate of RA oxidation using the NADPH/O2 system was slow for all isoforms (6-23 pmol/mg protein/min). LOOH-mediated oxidation was much faster (24-1078 pmol/mg protein/min), not isoform specific, but dependent upon the chemical nature of the LOOH. The order of efficiency of RA oxidation using LOOH was 13-hydroperoxy[S-(E,Z)]-9,11-octadecadienoic acid > 5-hydroperoxy[S-(E,Z,Z,Z)]-6,6,11,14-eicosatetraenoic acid > prostaglandin G2 > cumene hydroperoxide > tert-butylhydroperoxide > H2O2. Whereas submicromolar concentrations of 13-hydroperoxy[S-(E,Z)]- 9,11-octadecadienoic and 5-hydroperoxy[S-(E,Z,Z,Z)]-6,6,11,14- eicosatetraenoic acid oxidized RA at appreciable rates, micromolar concentrations were required for the other LOOH. These observations suggest that physiological LOOH, generated by the arachidonic acid-lipoxygenase system, may be involved in the self-induced oxidative catabolism of RA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383004

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

2.  Arachidonic acid-mediated cooxidation of all-trans-retinoic acid in microsomal fractions from human liver.

Authors:  L Nadin; M Murray
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol.

Authors:  Peter H Bui; Erin L Hsu; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2009-08-27       Impact factor: 4.436

4.  Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid.

Authors:  Masahiko Kawai; Jie Chen; Catherine Y S Cheung; Thomas K H Chang
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

5.  Modulation of all-trans retinoic acid pharmacokinetics by liarozole.

Authors:  V A Miller; J R Rigas; J R Muindi; W P Tong; E Venkatraman; M G Kris; R P Warrell
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids.

Authors:  Houli Jiang; Fiona E Harrison; Kavita Jain; Samantha Benjamin; James M May; Joan P Graves; Darryl C Zeldin; John R Falck; Bruce D Hammock; John C McGiff
Journal:  Adv Biosci Biotechnol       Date:  2012-06-01

Review 7.  The relationships between cytochromes P450 and H2O2: Production, reaction, and inhibition.

Authors:  Matthew E Albertolle; F Peter Guengerich
Journal:  J Inorg Biochem       Date:  2018-05-23       Impact factor: 4.155

8.  Study on cytochrome p-450 dependent retinoic Acid metabolism and its inhibitors as potential agents for cancer therapy.

Authors:  Mobasher Ahmad
Journal:  Sci Pharm       Date:  2011-08-12

9.  Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonist.

Authors:  Chie Koshiishi; Takanori Kanazawa; Eric Vangrevelinghe; Toshiyuki Honda; Shinji Hatakeyama
Journal:  Heliyon       Date:  2019-11-19

10.  Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.

Authors:  K Takitani; H Tamai; T Morinobu; N Kawamura; M Miyake; T Fujimoto; M Mino
Journal:  Jpn J Cancer Res       Date:  1995-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.